IS8500A - 7-[4-(4-klórbensýloxý)bensensúlfónýl]-8-metoxý-3-metýl-2,3,4,5-tetrahýdró-1H-3-bensasepíníummaleat eða tósýlat sem sefandi efni - Google Patents

7-[4-(4-klórbensýloxý)bensensúlfónýl]-8-metoxý-3-metýl-2,3,4,5-tetrahýdró-1H-3-bensasepíníummaleat eða tósýlat sem sefandi efni

Info

Publication number
IS8500A
IS8500A IS8500A IS8500A IS8500A IS 8500 A IS8500 A IS 8500A IS 8500 A IS8500 A IS 8500A IS 8500 A IS8500 A IS 8500A IS 8500 A IS8500 A IS 8500A
Authority
IS
Iceland
Prior art keywords
chlorobenzyloxy
benzenesulfonyl
tosylate
tetrahydro
methoxy
Prior art date
Application number
IS8500A
Other languages
English (en)
Icelandic (is)
Inventor
Clapham David
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IS8500A publication Critical patent/IS8500A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
IS8500A 2003-11-28 2006-06-08 7-[4-(4-klórbensýloxý)bensensúlfónýl]-8-metoxý-3-metýl-2,3,4,5-tetrahýdró-1H-3-bensasepíníummaleat eða tósýlat sem sefandi efni IS8500A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0327740.7A GB0327740D0 (en) 2003-11-28 2003-11-28 Novel compounds
PCT/EP2004/013416 WO2005051916A1 (en) 2003-11-28 2004-11-25 7-[4-(4-chlorobenzyloxy) benzenesulfonyl]-8-methoxy-3-methyl-2,3,4,5-tetrahydro-1h-3-benzazepinium maleate or tosylate as antipsychotics

Publications (1)

Publication Number Publication Date
IS8500A true IS8500A (is) 2006-06-08

Family

ID=29798028

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8500A IS8500A (is) 2003-11-28 2006-06-08 7-[4-(4-klórbensýloxý)bensensúlfónýl]-8-metoxý-3-metýl-2,3,4,5-tetrahýdró-1H-3-bensasepíníummaleat eða tósýlat sem sefandi efni

Country Status (18)

Country Link
US (1) US20070275948A1 (https=)
EP (1) EP1687279A1 (https=)
JP (1) JP2007512285A (https=)
KR (1) KR20060103322A (https=)
CN (1) CN1906170A (https=)
AR (1) AR046719A1 (https=)
AU (1) AU2004293179A1 (https=)
BR (1) BRPI0417029A (https=)
CA (1) CA2547444A1 (https=)
GB (1) GB0327740D0 (https=)
IL (1) IL175663A0 (https=)
IS (1) IS8500A (https=)
MA (1) MA28177A1 (https=)
NO (1) NO20062970L (https=)
RU (1) RU2006122959A (https=)
TW (1) TW200528433A (https=)
WO (1) WO2005051916A1 (https=)
ZA (1) ZA200603781B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0510599D0 (en) * 2005-05-24 2005-06-29 Glaxo Group Ltd Novel compounds
GB0603087D0 (en) * 2006-02-15 2006-03-29 Glaxo Group Ltd Novel use
JP5989965B2 (ja) * 2008-01-08 2016-09-07 メルク シャープ エンド ドーム リミテッド 2−{4−[(3s)−ピペリジン−3−イル]フェニル}−2h−インダゾール−7−カルボキサミドの薬学的に許容される塩
CA2970502A1 (en) * 2014-12-12 2016-06-16 The Schepens Eye Research Institute, Inc. Gdnf induction for the treatment of retinal disorders
US11225487B2 (en) 2017-02-17 2022-01-18 Trevena, Inc. 7-membered aza-heterocyclic containing δ-opioid receptor modulating compounds, methods of using and making the same
US20210347758A1 (en) 2018-10-03 2021-11-11 Tesaro, Inc. Crystalline Forms of Niraparib Freebase
JP2023546729A (ja) * 2020-10-27 2023-11-07 トレベナ・インコーポレイテッド デルタオピオイドモジュレーターの結晶形及び非晶形
CN115998724B (zh) * 2023-03-28 2023-06-16 中国人民解放军军事科学院军事医学研究院 布洛芬在抗幻觉作用药物中的新用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005518414A (ja) * 2001-12-21 2005-06-23 スミスクライン ビーチャム パブリック リミテッド カンパニー ドーパミン受容体のモジュレーターとしての7−スルホニル−3−ベンゾアゼピン誘導体およびcns障害の治療のためのその使用
KR20040081201A (ko) * 2002-02-13 2004-09-20 글락소 그룹 리미티드 항정신병제로서 벤젠술폰아미드 유도체
AR040126A1 (es) * 2002-05-29 2005-03-16 Glaxo Group Ltd Compuesto de fenilsulfonilo, composicion farmaceutica que lo comprende y su uso para la elaboracion de un medicamento

Also Published As

Publication number Publication date
US20070275948A1 (en) 2007-11-29
JP2007512285A (ja) 2007-05-17
KR20060103322A (ko) 2006-09-28
AR046719A1 (es) 2005-12-21
RU2006122959A (ru) 2008-01-10
CN1906170A (zh) 2007-01-31
ZA200603781B (en) 2007-09-26
BRPI0417029A (pt) 2007-02-06
IL175663A0 (en) 2006-09-05
AU2004293179A1 (en) 2005-06-09
MA28177A1 (fr) 2006-09-01
WO2005051916A1 (en) 2005-06-09
TW200528433A (en) 2005-09-01
NO20062970L (no) 2006-08-21
EP1687279A1 (en) 2006-08-09
GB0327740D0 (en) 2003-12-31
CA2547444A1 (en) 2005-06-09

Similar Documents

Publication Publication Date Title
NO20043022L (no) 5,6-diaryl-pyrazin-2-amid-derivater som CB1-antagonister
IL168102A0 (en) Chk-, pdk-and akt-inhibitory pyrimidines, their production and use as pharmaceutical agents
IL177798A0 (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives
NO20023485L (no) 1,3-disubstituerte pyrrolidiner som alfa-2- adrenoceptorantagonister
PT1381363E (pt) Derivados de imidazo-(1,2-a)-piridina como antagonistas mglur5
IS8698A (is) Súlfónamíðaafleiður, framleiðsla þeirra og notkunþeirra sem lyfja
NO20034439L (no) Benzamidinderivater
IS6847A (is) Eterafleiður, nytsamlegar sem hindrar PDE4 samsætuensíma
PL375874A1 (pl) Wodne kompozycje farmaceutyczne 2,6-diizopropylofenolu
NO20034338L (no) Ekspanderbart verktöy nede i brönnen
IS7088A (is) Nýjar afleiður oxasólidínóna sem bakteríueyðandi lyf
IS7388A (is) Bensensúlfónamíðafleiður sem sefandi efni
NO20051956D0 (no) Salmeterol superfin formulering
PT1514871E (pt) Diespiro 1,2,4-trioxolanos contra a malária
IS8500A (is) 7-[4-(4-klórbensýloxý)bensensúlfónýl]-8-metoxý-3-metýl-2,3,4,5-tetrahýdró-1H-3-bensasepíníummaleat eða tósýlat sem sefandi efni
IS7488A (is) Dreyfasamsetning í föstu formi
NO20042980L (no) 3,4-dihydro-1H-isokinolin-2-yl-derivater
EP1610795A4 (en) HETEROCYCLIC SUBSTITUTED 1,4-DIHYDRO-4-OXO-1,8-NAPHTHPYRIDINE ANALOGUE
MXPA03006648A (es) Compuestos antitombroticos, su preparacion y su utilizacion como medicamentos.
IL182314A0 (en) 1,2,4-triazolylaminoaryl (heteroaryl) sulfonamide derivatives
IL173004A0 (en) Benzoxazinone-derived sulfonamide compounds, their preparation and use as medicaments
IS7705A (is) 4-(3,5-Dísýanófenoxý) pýrasól afleiður til notkunar sem bakritunarstillar við meðhöndlun á m.a. eyðniveirunni
ITPR20040020A1 (it) Attrezzo da palestra per traslare l'appoggio rovesciato.
HK1093733A (en) 7-[4-(4-chlorobenzyloxy) benzenesulfonyl]-8-methoxy-3-methyl-2,3,4,5-tetrahydro-1h-3-benzazepinium maleate or tosylate as antipsychotics
IS7131A (is) Nýjar 2,4-díamínóþíasól afleiður